Faculty Bibliography

The Food and Drug Administration has given a California company approval to conduct the world's first full-scale test of a vaccine to prevent infection with the virus that causes AIDS, the company announced Wednesday. The announcement brought expressions of cautious hope among health officials and advocates for people with AIDS. HIV, the virus that causes AIDS, has infected an estimated 30 million people in the world, and many experts say it will take a vaccine to stop the worsening epidemic. Scientists are divided over which experimental vaccines to approve for full-scale testing and when to do so. No vaccine is 100 percent effective. Some experts favor testing any promising vaccine, even if it is likely to protect only a small proportion of recipients, saying that something is better than nothing in a health emergency

The Food and Drug Administration has given a California company approval to conduct the world's first full-scale test of a vaccine to prevent infection with the AIDS virus, the company announced Wednesday. The announcement brought expressions of cautious hope among health officials and advocates for people with AIDS. HIV, the AIDS virus, has infected an estimated 30 million people in the world, and many experts say it will take a vaccine to stop the worsening epidemic. But scientists are sharply divided over when and which experimental vaccines to approve for full-scale testing. No vaccine is 100 percent effective. Some experts favor testing any promising vaccine, even if it is likely to protect only a small proportion of recipients, arguing that something is better than nothing in a health emergency

The Food and Drug Administration has given approval to a Bay area company to conduct the world's first full-scale test of a vaccine to prevent infection with the AIDS virus, the company announced Wednesday. The announcement brought expressions of cautious hope among health officials and advocates for people with AIDS. HIV, the AIDS virus, has infected an estimated 30 million people in the world, and many experts say it will take a vaccine to stop the worsening epidemic. But scientists are sharply divided over when and which experimental vaccines to approve for full-scale testing. No vaccine is 100 percent effective. Some experts favor testing any promising vaccine, even if it is likely to protect only a small proportion of recipients, arguing that something is better than nothing in a health emergency

The Food and Drug Administration has given a California company approval to conduct the world's first full-scale test of a vaccine to prevent infection with the AIDS virus, the company announced Wednesday. The experiment is to involve 5,000 uninfected individuals in up to 40 clinics in the United States and Canada and 2,500 volunteers in 16 clinics in Thailand over the next four years, the company, VaxGen Inc. of South San Francisco, said. The announcement brought expressions of cautious hope among health officials and advocates for people with AIDS. HIV, the AIDS virus, has infected an estimated 30 million people in the world, and many experts say it will take a vaccine to stop the worsening epidemic

The Food and Drug Administration has given a California company approval to conduct the world's first full-scale test of a vaccine to prevent infection by the virus that causes AIDS, the company announced on Wednesday. Florida will almost surely be chosen as one of the sites where the vaccine will be tested, VaxGen spokeswoman Nicole Lynch said. South Florida, with its diverse mix of AIDS patients, is a prime location, she said. The announcement brought expressions of cautious hope among health officials and advocates for people with AIDS. HIV, the virus that causes AIDS, has infected an estimated 30 million people in the world, and many experts say it will take a vaccine to stop the worsening epidemic

The Food and Drug Administration has given a California company approval to conduct the world's first full-scale test of a vaccine to prevent infection with the AIDS virus, the company announced Wednesday. The experiment is to involve 5,000 uninfected individuals in as many as 40 clinics in the United States and Canada and 2,500 volunteers in 16 clinics in Thailand during the next four years, VaxGen Inc. said. The South San Francisco company said it expects to receive approval from Thai health officials to begin testing in that country later this year. The VaxGen vaccine was safe in earlier tests involving 1,200 volunteers beginning in March 1992 and induced antibodies in more than 99 percent of the vaccinated participants, the company said. The question the new tests aim to answer is how effective the experimental vaccine will be among people who are exposed to HIV because of high-risk sexual practices or from injecting drugs

The Food and Drug Administration has given a California company approval to conduct the world's first full-scale test of a vaccine to prevent infection with the AIDS virus, the company announced Wednesday. The announcement brought expressions of cautious hope among health officials and advocates for people with AIDS. HIV, the AIDS virus, has infected an estimated 30 million people in the world, and many experts say it will take a vaccine to stop the worsening epidemic. But scientists are sharply divided over when and which experimental vaccines to approve for full-scale testing. No vaccine is 100 percent effective. Some experts favor testing any promising vaccine, even if it is likely to protect only a small proportion of recipients, arguing that something is better than nothing in a health emergency